China remains one of the largest and most complex equity markets globally. For institutional investors, the key question is no longer simply whether to invest in China, but how China should fit within an emerging market allocation.

Recent regulatory developments, geopolitical tensions, and shifting economic dynamics have prompted many investors to reassess their China exposure.

If the Unboxing China webinar raised questions about these developments, this discussion offers an opportunity to explore the implications for portfolio construction and long-term investment strategy.

Who this discussion is for

This discussion may be useful if you are:

• • reviewing China exposure within an emerging market allocation

  • assessing whether China should be treated as a standalone allocation

  • evaluating specialist managers investing in Chinese equities

Many investors are currently asking similar questions:

• • Should China remain part of emerging market allocations?

  • Are current China equity valuations cyclical or structural?

  • Does specialist manager selection improve outcomes in China

How this discussion can help

A conversation with the team can help explore:

• • the role of China within emerging market allocations

  • risks and opportunities in Chinese equities

  • specialist manager selection considerations

  • implications for portfolio construction

Book a discussion

If you would like to explore how China exposure may affect your portfolio, you can schedule a conversation with the team.

Prefer to stay informed instead?

You can also explore and subscribe to RisCura’s latest investment insights and research commentary